Ben Greenfield Fitness: Diet, Fat Loss And Performance
Ben's *Shocking* Self-Experiment With Semaglutide, The Surprising Facts About GLP-1 & Why GLP-1's May Not Be The Big, Scary Drugs You've Been Led To Believe, With Dr. Tyna Moore
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 1:00:59
- Mais informações
Informações:
Sinopse
All over the Internet, you hear about the risks of using GLP-1 agonists like Ozempic, Wegovy, and Victoza—such as muscle loss, depression, pancreatitis, nausea, vomiting, digestive distress, appetite suppression, and headaches. …but it turns out there’s a lot more to the story, including potential systemwide benefits that go far beyond appetite control and weight loss, and fewer side effects than the fearmongering suggests (which I myself have been guilty of!). The effects of my experiment with GLP-1 agonist semaglutide, how dosage impacts appetite and metabolism, and the importance of individualized strategies for balancing appetite control, blood sugar, and sleep quality…05:54 The cautious use of GLP-1 agonists, their powerful effects on appetite and cognitive health, and the importance of personalized dosing for cognitive and neuroprotective benefits…12:26 How GLP-1 agonists can help brain health and diabetes by improving metabolism, the importance of careful dosing, and why personalized approaches based